NEW YORK – Inso Biosciences, a startup developing sample preparation methods for high-molecular weight DNA for long-read sequencing, has raised $2.2 million in pre-seed financing.
VC firm 2048 Ventures led the round, joined by SOSV, Whitecap Venture Partners, Ataraxia Ventures, and CRCM Ventures.
In a statement, the firm said it plans to use the funding to develop a benchtop instrument to automate DNA extraction, purification, fragmentation, and sizing.
Inso Cofounder Harold Craighead, a professor emeritus at Cornell University, also cofounded the company that became Pacific Biosciences.
The company said it has now raised a total of $2.8 in financing and grants.